thirty-eight adults with acute lymphocytic leukemia ( all ) , 24 previously untreated and 14 previously treated , were entered into a study in which sequential , moderate-dose methotrexate and asparaginase were added to vincristine and dexamethasone ( moad ) for remission induction therapy .
C0003993
asparaginase
C0279194
moad